Concepedia
Statistics
Publications
32
Citations
2.3K
H-Index
21
Active since
2000
Affiliations
Seagen (United States)(Current)
University of Washington
Fred Hutch Cancer Center
Seattle University
University of Rochester
Weiping Zeng is an author at Seagen (United States) specializing in medicine, immunology, and cell biology.
Top concepts
MedicineImmunologyCell BiologyPharmacologyImmunotherapyTumor BiologyDrug DiscoveryBiochemistryInflammationNatural Sciences
Publications per year
2000–2023
SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey et al. · Blood · 2013 · 381 citations
A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation Technology
Scott C. Jeffrey, Patrick Burke, Robert P. Lyon et al. · Bioconjugate Chemistry · 2013 · 241 citations
Drug Target, Immunology, Molecular Biology +21
<i>Helicobacter</i> Infection Is Required for Inflammation and Colon Cancer in Smad3-Deficient Mice
Lillian Maggio‐Price, Piper M. Treuting, Weiping Zeng et al. · Cancer Research · 2006 · 206 citations · Full text
Development of orally active inhibitors of protein and cellular fucosylation
Nicole M. Okeley, Stephen C. Alley, Martha E. Anderson et al. · Proceedings of the National Academy of Sciences · 2013 · 183 citations · Full text
Vitro Fucosylation, Glycobiology, Immunology +21
<i>Helicobacter</i>-induced inflammatory bowel disease in IL-10- and T cell-deficient mice
Andrew Burich, Robert M. Hershberg, Kim Waggie et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2001 · 180 citations
1–5 of 32